Prevalence of Covishield COVID-19 Vaccine (ChAdOx1 nCoV-19) Adverse Effects among Health Care Workers in Sri Lanka

dc.contributor.author	Manilgama, S. R.
dc.contributor.author	Hettiarachchi, N.M.
dc.contributor.author	Jayasinghe, K.I.
dc.contributor.author	De Silva, S.
dc.contributor.author	Wanigaratne, T.
dc.contributor.author	Jayalath, T.
dc.contributor.author	Bandusiri, R.P.
dc.contributor.author	Suganthan, N.
dc.date.accessioned	2023-09-19T03:43:14Z
dc.date.available	2023-09-19T03:43:14Z
dc.date.issued	2021
dc.identifier.citation	Manilgama, S. R., Hettiarachchi, N. M., Jayasinghe, K. I., De Silva, S., Wanigaratne, T., Jayalath, T., ... & Kulaweera, M. T. D. (2022). Prevalence of covishield COVID-19 vaccine (chadox1 ncov-19) adverse effects among health care workers in sri lanka. International Journal of Infectious Diseases, 116, S61.	en_US
dc.identifier.uri	http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/9687
dc.language.iso	en	en_US
dc.publisher	Elsevier	en_US
dc.subject	COVID-19	en_US
dc.subject	Covishield Vaccine	en_US
dc.title	Prevalence of Covishield COVID-19 Vaccine (ChAdOx1 nCoV-19) Adverse Effects among Health Care Workers in Sri Lanka	en_US
dc.type	Article	en_US